Abstract
Assessing Adoption of Standard of Care and Comparing Clinical and Demographic Differences in First-Line (1L) Treatment (Tx) of Chronic Lymphocytic Leukemia (CLL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have